Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02215096
Title Dose-finding Study of GSK2636771 When Administered in Combination With Enzalutamide in Male Subjects With Metastatic Castration-Resistant Prostate Cancer
Recruitment Completed
Gender male
Phase Phase I
Variant Requirements Yes
Sponsors GlaxoSmithKline
Indications

prostate adenocarcinoma

Therapies

Enzalutamide

GSK2636771

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
GSK Investigational Site Duarte California 91010 United States Details
GSK Investigational Site Los Angeles California 90033 United States Details
GSK Investigational Site Los Angeles California 90095 United States Details
GSK Investigational Site Washington District of Columbia 20007 United States Details
GSK Investigational Site Detroit Michigan 48201 United States Details
GSK Investigational Site New York New York 10016 United States Details
GSK Investigational Site Houston Texas 77030 United States Details
GSK Investigational Site London SE1 9RT United Kingdom Details
GSK Investigational Site Sutton SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field